The CDC issued an alert to doctors about a shortage of certain doses of an RSV antibody drug Beyfortus given to newborns and infants to prevent RSV. Certain dosages are limited.
The agency warns that nirsevimab, the RSV immunization for infants, should be reserved for babies at the highest risk for severe RSV. Here’s what to do to protect your baby if you can’t get the shot.
Argh, you’re feeling sick again. You don’t want to take off work or go to the doctor if you don’t have to, but you also don’t want to be that person who infects the whole office (substitute “kid” and “classroom,” if applicable). You might have toughed it out before the pandemic, but the etiquette is different now. So how can you be sure about what you have, or if — and for how long — you need to stay home? Here’s what infectious disease experts want you to know about some of the most common adul
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the healthcare industry stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed.
The advisory committee on immunizations for the Centers for DIsease Control and Prevention (CDC) voted to recommend an RSV vaccine designed to give newborn infants protection against the virus before they’re born. The CDC’s Advisory Committee on Immunization Practices (ACIP) voted 11-1 in favor of approving Pfizer’s Abrysvo for use in pregnant women during weeks…